INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

73,431 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
TM
Taylor Bernadette MSr Executive Vice President
FULTFULTON FINANCIAL CORP
Gift
G—
425 sh
Dec 5, 2025Dec 8, 2025
Page 1676 of 1836
← PrevNext →
traded Dec 5, 2025
+3d
SEC Form 4

Evidence

8
BH
Beckwith Van H.EVP, Secretary and CLO
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$247K
8,854 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC Form 4

Evidence

8
RM
Richard MarkPresident - Western Hemisphere
HALHALLIBURTON CO
Tax withholding
F$199K
7,383 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

8
KA
Kuruvilla AbrahamChief Technology Officer
ACIWACI WORLDWIDE, INC.
Disposition to issuer
D$59K
1,283 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

7
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
4,290 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

7
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$865K
45.0K sh
Dec 8, 2025Dec 8, 2025
traded Dec 8, 2025
+0dSEC Form 4

Evidence

5
KA
Kuruvilla AbrahamChief Technology Officer
ACIWACI WORLDWIDE, INC.
Disposition to issuer
D$39K
839 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

5
MM
Momper Sara MarieVP, CAO
HPHelmerich & Payne, Inc.
Tax withholding
F$9,024
302 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC Form 4

Evidence

5
FK
Franzese Yvonne K.Chief Human Resources Officer
CNOCNO Financial Group, Inc.
Tax withholding
F$19K
475 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC Form 4

Evidence

3
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
4,157 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

2
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Option exercise · 10b5-1 plan
M$70K
7,500 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

2
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$52K
4,290 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

2
BH
Beckwith Van H.EVP, Secretary and CLO
HALHALLIBURTON CO
Tax withholding · 10b5-1 plan
F$155K
5,746 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

1
BM
Berman David MHEAD OF R&D
IMCRImmunocore Holdings plc
Option exercise · 10b5-1 plan
M$547K
31.3K sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
166.4K sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC Form 4

Evidence

0
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Option exercise · 10b5-1 plan
M—
7,500 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$17K
4,157 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
44.9K sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
BM
Berman David MHEAD OF R&D
IMCRImmunocore Holdings plc
Option exercise · 10b5-1 plan
M$9,987
572 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC Form 4

Evidence

0
BM
Berman David MHEAD OF R&D
IMCRImmunocore Holdings plc
Option exercise · 10b5-1 plan
M—
31.3K sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
44.9K sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
BM
Berman David MHEAD OF R&D
IMCRImmunocore Holdings plc
Option exercise · 10b5-1 plan
M—
572 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
166.4K sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
HX
Hao XinyanChief Operating Officer
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$32K
800 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC Form 4

Evidence

0
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Tax withholding · 10b5-1 plan
F$137K
13.8K sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC Form 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$35K
4,157 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
2,500 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
4,157 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC Form 4

Evidence

52
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale
SELL$480K
10.0K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

52
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$9,006
1,000 sh
Dec 2, 2025Dec 5, 2025
traded Dec 2, 2025
+3dSEC Form 4

Evidence

51
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$105K
1,414 sh
Nov 26, 2025Dec 5, 2025
traded Nov 26, 2025
+9dSEC Form 4

Evidence

48
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
378 sh
Nov 26, 2025Dec 5, 2025
traded Nov 26, 2025
+9dSEC Form 4

Evidence

47
NS
Neal John ScottChief Merchandising Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$1.24M
14.6K sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

46
LM
Lee Bryan MChief Financial Officer
FIVNFive9, Inc.
Open-market sale
SELL$269K
13.2K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

42
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$14K
1,500 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

42
RS
Rich StuartDirector, Chief Medical Officer
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$23K
2,500 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

41
WS
Wilkins Edward ScottDirector
CINFCINCINNATI FINANCIAL CORP
Open-market purchase
BUY$23K
140 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

41
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$665K
8,405 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

40
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Open-market sale
SELL$30K
2,106 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence